SC Filed 2021-04-02 Event — SEC 0001104659-21-046072 →

BAKER BROS. ADVISORS LP → Talis Biomedical Corp

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

14 filings by this filer

13 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Institutional Consensus · 2023-12-31

Held by elite portfolio managers

1 holder · $1.11M

Greenlight Capital

Other Filings by BAKER BROS. ADVISORS LP

Filed	Form	Issuer	Stake	Shares
2024-10-08	SC	Kiniksa Pharmaceuticals International, plc KNSA	—	—	view →
2023-10-05	SC	MADRIGAL PHARMACEUTICALS, INC. MDGL	—	—	view →
2022-07-20	SC	Immunocore Holdings plc IMCR	—	—	view →
2021-10-01	SC	Kodiak Sciences Inc. KOD	—	—	view →
2021-01-05	SC	IGM Biosciences, Inc.	—	—	view →
2018-07-02	SC	Erytech Pharma S.A.	—	—	view →
2018-05-03	SC	INCYTE CORP INCY	—	—	view →
2018-05-02	SC	SEATTLE GENETICS INC /WA	—	—	view →
2018-03-23	SC	DBV Technologies S.A. DBVTF	—	—	view →
2018-03-12	SC	GENOMIC HEALTH INC	—	—	view →
2018-03-06	SC	IDERA PHARMACEUTICALS, INC.	—	—	view →
2018-02-05	SC	SEATTLE GENETICS INC /WA	—	—	view →
2018-01-22	SC	BeiGene, Ltd. BEIGF	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →